Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Patient-specific (endogenous) and population-specific (exogenous) risk factor analysis is identifying novel physical and chemical exposures which might be time-linked to the development of
amyotrophic lateral sclerosis
(
ALS
) and other motor neuron diseases. Electric injury in a number of case-control studies as well as prolonged exposure at work and home to agricultural chemicals in pesticides and herbicides have been identified as significant risk factors. Heavy exercise, trauma with or without bone fractures and heavy metal exposure at work have not been confirmed as risk factors. Surprisingly, occupation as a pilot or navigator has recently been identified as a potential risk factor, which will need to be confirmed. The introduction of international patient registries in North America (
ALS
CARE) and in Europe (
ALS
HPS
) will facilitate future studies on the prognosis of
ALS
, adherence to standards of practice, quality of life and patient outcome studies. An initial survey of the
ALS
Patient Care Database in January 1999, when nearly 1800 patients had been entered across North America, indicated the median time from
ALS
onset to diagnosis is 14 months when no second opinion is requested, 12 months if the patient requests a second opinion and 10 months when the neurologist requests an additional opinion. No significant difference was found in the median time to diagnose sporadic
ALS
patients compared with familial
ALS
patients.
...
PMID:Risk factors in the early diagnosis of ALS: North American epidemiological studies. ALS CARE Study Group. 1146 21